We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Prazosin hydrochloride capsules, USP 2mg (Novitium Pharma, USA)
Section 19A approved medicine
Prazosin hydrochloride capsules, USP 2mg (Novitium Pharma, USA)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
APO-PRAZOSIN prazosin (as hydrochloride) 2mg tablet blister pack - ARTG 73862
MINIPRESS prazosin 2 mg (as hydrochloride) tablet blister pack - ARTG 10757
MINIPRESS prazosin 2 mg (as hydrochloride) tablet blister pack - ARTG 10757
Indication(s)
In patients with hypertension.
Prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. It can be used as the initial and sole agent or it may be employed in a treatment programme in conjunction with other antihypertensive agents.
Images
